Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $1.68 per share for the year ending 2025.
- CATALYST PHARMACEUTICALS, INC. showed an increase of +28.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from CATALYST PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: $0.06 (loss) per share | Q3 2018: $0.08 (loss) per share | Q1 2019: $0.01 (loss) per share | Q2 2019: $0.10 per share | Q3 2019: $0.13 per share | Q4 2019: $0.07 per share | Q1 2020: $0.10 per share | Q2 2020: $0.09 per share | Q3 2020: $0.41 per share | Q1 2021: $0.07 per share | Q2 2021: $0.11 per share | Q3 2021: $0.10 per share | Q1 2022: $0.12 per share | Q2 2022: $0.20 per share | Q3 2022: $0.20 per share | Q1 2023: $0.26 per share | Q2 2023: $0.33 per share | Q3 2023: $0.29 (loss) per share | Q1 2024: $0.19 per share | Q2 2024: $0.33 per share | Q3 2024: $0.35 per share | Q1 2025: $0.45 per share | Q2 2025: $0.41 per share | Q3 2025: $0.42 per share.
- Over the full 8 years of available data (2018 to 2025), CATALYST PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 609.1%.
- Historical annual values: Fiscal year 2025: $1.68 per share | Fiscal year 2024: $1.31 per share | Fiscal year 2023: $0.63 per share | Fiscal year 2022: $0.75 per share | Fiscal year 2021: $0.37 per share | Fiscal year 2020: $0.71 per share | Fiscal year 2019: $0.30 per share | Fiscal year 2018: $0.33 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: